One study found no correlation between AREG mRNA expression and staging or histological tumour types, and another study reported a significantly shorter median survival in patients with pro-AREG-positive tumours (Kitadai et al. 1993; Yoshida et al. 2012). The gene discussed is AREG; the disease is neoplasm.